What veterinarians should know about DEA reverse distribution

CURRENT FULL VERSION: Veterinary practices are being reminded that controlled-substance compliance doesn’t stop at storage and recordkeeping. It also extends to how expired, damaged, or unwanted drugs leave the building. That’s the focus of a VETgirl podcast published March 2, 2026, in which host Dr. Justine Lee spoke with William Doxey, COO of Easy Rx Cycle, about reverse distribution and the DEA rules veterinarians need to understand when disposing of controlled drugs. In the episode, Doxey framed reverse distribution plainly: if a clinic has expired or leftover controlled substances it needs to get rid of, it sends them to a DEA-registered reverse distributor for proper disposal. He also noted that his company specializes in destroying controlled substances, typically by incineration, and returning the supporting paperwork to the clinic. (podcasts.apple.com)

The timing matters because reverse distribution is colliding with a broader practice-management issue: transitions. Recent dvm360 coverage has emphasized that a DEA registration belongs to the individual registrant, not the employer, and that veterinarians can face real exposure if a practice continues to order, store, or manage controlled substances under a doctor’s registration after that person leaves or changes roles. That makes disposal planning part of a larger compliance conversation that includes onboarding, offboarding, relocation, and clinic closure. (dvm360.com)

DEA’s own guidance lays out the framework. In the agency’s Practitioner’s Manual, DEA says practitioners may dispose of out-of-date, damaged, unusable, or unwanted office-stock controlled substances by transferring them to a DEA-registered reverse distributor. For Schedule II drugs, the reverse distributor must issue DEA Form 222 to the practitioner. For Schedule III-V drugs, the practitioner must maintain a record of the date and manner of disposal, the recipient’s name, address, and registration number, and the quantity disposed of. DEA also states that the reverse distributor is responsible for completing DEA Form 41 to document destruction. The VETgirl discussion added a practical layer here, pointing listeners to the core documents clinics are likely to encounter: Form 222 for Schedule II transfers, a certificate of destruction, DEA Form 41, and manifests documenting Schedule III-V drugs sent out for disposal. (deadiversion.usdoj.gov)

That distinction is important because Form 41 is often misunderstood in practice. DEA says registrants use Form 41 when destroying lawfully possessed controlled substances outside the reverse-distributor pathway, while reverse distributors complete the destruction record when they receive drugs for disposal through that channel. DEA also notes that registrants must keep disposal records for at least two years, and that office-stock controlled substances can’t simply be dropped into public take-back boxes or events intended for ultimate users. The podcast also stressed that, while most veterinary clinics primarily handle Schedule III-V drugs and only rarely deal with Schedule II medications, even those more routine disposals still require complete manifests and other supporting records. (deadiversion.usdoj.gov)

Industry educators have been warning for some time that veterinary teams still get tripped up by DEA basics. dvm360’s recent coverage of common veterinary DEA violations points to recurring confusion around registration, storage, and accountability, while a related CE program frames controlled-substance compliance as an area where veterinarians often underestimate how directly their credentials are tied to day-to-day practice operations. That broader reaction suggests the VETgirl episode is tapping into an ongoing pain point, not introducing a niche issue. (ce.dvm360.com)

Why it matters: For veterinary professionals, reverse distribution is really a risk-management issue. When a hospital changes ownership, shutters a location, swaps medical directors, or loses an associate, controlled drugs can become the most legally sensitive assets left behind. If there’s no clean chain of custody, no current inventory, or no documented disposal plan, the veterinarian whose DEA registration is attached to that stock may be exposed. The practical takeaway is that practices should treat reverse distribution as part of a standard operating procedure: reconcile inventory, identify expired or unusable products, confirm which items require Form 222 handling, verify the reverse distributor’s registration status, and retain all transfer and destruction records in an audit-ready file. For many clinics, that also means understanding the everyday paperwork Doxey highlighted—certificates of destruction and manifests for Schedule III-V drugs—not just the better-known DEA forms. Those steps won’t eliminate regulatory risk, but they can sharply reduce it. (deadiversion.usdoj.gov)

What to watch: The next development to watch isn’t likely to be a new DEA rule specific to veterinarians, but stronger operationalization inside practices and consolidators. Expect more hospitals to build DEA-specific transition checklists, clarify who controls ordering authority, and formalize disposal workflows before departures or location changes. As more CE content and trade coverage focus on these gaps, reverse distribution may become a standard compliance checkpoint rather than an afterthought. That would be a meaningful shift for veterinary medicine, where DEA problems often start with routine processes that no one clearly owns. (podcasts.apple.com)